30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Faheem Hasnain

Track

Insider profile

Currently holds positions in Mirati Therapeutics Inc, Gossamer Bio Inc, Forte Biosciences Inc and Kura Oncology Inc

Performance

Overall performance
2.7
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 61% 68% 82%
Transactions
15 73% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -81%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Chairman of the Board Mirati Therapeutics Inc Feb. 15, 2019 -
Executive Chairman of the Board Gossamer Bio Inc July 1, 2018 -
Independent Chairman of the Board Forte Biosciences Inc Oct. 1, 2014 -
Lead Independent Director Kura Oncology Inc March 1, 2020 -
Independent Director Kura Oncology Inc April 1, 2015 - March 1, 2020
Chairman of the Board Immunic Inc Sept. 6, 2017 - April 12, 2019
Director Immunic Inc Aug. 11, 2016 - Sept. 6, 2017
Faheem Hasnain's trades of Kura Oncology Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-10 2025-12-09
PlS Planned sale
21,422 +18.8%
377.24
US$1,049,369 		21,422 +18.8% 377.24 US$1,049,369
2025-12-09 2025-12-09
PrS Proposed sale
55,159
235.61
US$3,045,296 		55,159 235.61 US$3,045,296
2025-03-24 2025-03-21
PlS Planned sale
32,060 -32.7%
85.88
US$2,991,775 		32,060 -32.7% 85.88 US$2,991,775
2025-03-21 2025-03-21
PrS Proposed sale
30,000
7.85
US$235,500 		30,000 7.85 US$235,500
2024-06-24 2024-06-21
B Purchase
372,000 +7.4%
0.67
US$250,282 		372,000 +7.4% 0.67 US$250,282
2024-03-28 2024-03-27
S Sale
23,172 -16.2%
1.16
US$26,773 		23,172 -16.2% 1.16 US$26,773
2023-08-14 2023-08-11
B Purchase
10,791 +inf%
27.80
US$299,990 		10,791 +inf% 27.80 US$299,990
2023-03-22 2023-03-22
B Purchase
440,500 +10.9%
1.14
US$503,580 		440,500 +10.9% 1.14 US$503,580
2023-03-22 2023-03-21
B Purchase
269,389 +7.1%
1.20
US$322,324 		269,389 +7.1% 1.20 US$322,324
2023-03-22 2023-03-20
B Purchase
168,683 +4.7%
1.03
US$174,486 		168,683 +4.7% 1.03 US$174,486
2022-07-15 2022-07-15
B Purchase
138,696 +4.0%
7.21
US$999,998 		138,696 +4.0% 7.21 US$999,998
2022-03-24 2022-03-23
S Sale
19,035 -11.7%
8.92
US$169,697 		19,035 -11.7% 8.92 US$169,697
2020-10-14 2020-10-14
B Purchase
96,520 +2.9%
10.36
US$999,995 		96,520 +2.9% 10.36 US$999,995
2019-09-27 2019-09-27
B Purchase
10,000 +0.3%
16.80
US$167,980 		10,000 +0.3% 16.80 US$167,980
2019-06-03 2019-05-30
B Purchase
250 +0.1%
5.15
US$1,287 		250 +0.1% 5.15 US$1,287
2019-06-03 2019-05-30
B Purchase
3,890 +1.6%
5.30
US$20,613 		3,890 +1.6% 5.30 US$20,613
2019-06-03 2019-05-30
B Purchase
38,860 +19.2%
4.59
US$178,414 		38,860 +19.2% 4.59 US$178,414
2018-09-17 2018-09-13
US Immunic Inc (IMUX)
S Sale
118,243 -96.3%
0.44
US$51,767 		118,243 -96.3% 0.44 US$51,767
2018-09-17 2018-09-13
US Immunic Inc (IMUX)
S Sale
59,200 -32.5%
0.44
US$25,912 		59,200 -32.5% 0.44 US$25,912
2017-09-15 2017-09-14
US Immunic Inc (IMUX)
B Purchase
59,200 +48.2%
4.19
US$247,870 		59,200 +48.2% 4.19 US$247,870
2017-04-21 2017-04-19
B Purchase
100,000 +97.2%
10.00
US$1,000,000 		100,000 +97.2% 10.00 US$1,000,000
2016-08-15 2016-08-12
US Immunic Inc (IMUX)
B Purchase
118,243 +2627.6%
5.92
US$699,999 		118,243 +2627.6% 5.92 US$699,999